Hydrazine derivatives

Archiv der Pharmazie

Volumn 331, Issue 10, 1998, Pages 308-312

  Rehse, Klaus ^a   Shahrouri, Tawfig ^a  

^a FREIE UNIVERSITÄT BERLIN   (Germany)

Author keywords

Antihypertensive properties; Antithrombotic effects; Inhibition of platelet aggregation; Nitrosohydrogen formation; NO2 NO3 formation

Indexed keywords

HYDRAZINE DERIVATIVE; HYDROGEN PEROXIDE; KETAMINE; NITRIC OXIDE; PHENYLHYDRAZINE; XYLAZINE; FIBRINOLYTIC AGENT; NITRIC OXIDE DONOR; VASODILATOR AGENT;

ANTIHYPERTENSIVE ACTIVITY; ARTICLE; BLOOD CLOT LYSIS; CHEMICAL REACTION; DRUG EFFECT; DRUG MECHANISM; HUMAN; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; THROMBOCYTE AGGREGATION; THROMBOGENESIS; THROMBOSIS; VASODILATATION; CHEMISTRY; IN VITRO STUDY; SYNTHESIS;

FIBRINOLYTIC AGENTS; HUMANS; HYDRAZINES; NITRIC OXIDE DONORS; PLATELET AGGREGATION; VASODILATOR AGENTS;

EID: 0032177348     PISSN: 03656233     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1521-4184(199810)331:10<308::AID-ARDP308>3.3.CO;2-U     Document Type: Article

References (22)

1. M. Kämpfe, PhD Thesis, FU Berlin 1987.
2. L.J. Ignarro, Sem. Hematol. 1989, 26, 63-76.
3. W.D. Bussmann, H. Just, Vasoaktive Substanzen bei Herzinsuffizienz, Springer Verlag, Berlin-Heidelberg 1986.
4. N. Kornblum, Org. Reactions 1957, Vol. 2, 287, 339.
5. E. Fischer, Ber. Dtsch. Chem. Ges. 1898, 31, 121.
6. S. Haller, Ber. Dtsch. Chem. Ges. 1885, 18, 92.
7. E. Fischer, Liebigs Ann. Chem. 1877, 190, 102.
8. F.D. Chattaway, J. Chem. Soc. 1908, 93, 270, 274.
9. D. Behrens, PhD Thesis, Universität Greifswald 1954.
10. E. Fischer, Liebigs Ann. Chem. 1878, 190, 89.
11. H. Strache, M. Kitt, Monatsh. Chem. 1892, 13, 316.
12. C.K. Mittal, F. Murad, Guanylate Cyclase: Regulation of cyclic GMP Metabolism, in J.A. Nathanson, J.W. Kebabian (eds.), Handbook of Experimental Pharmacology 58/I, Cyclic Nucleotides I, Springer, Berlin, Heidelberg, New York 1982, pp. 225-260.
13. K. Rehse, M. Kämpfe, K.-J. Schleifer, Arch. Pharm. (Weinheim) 1993, 326, 483-487.
14. K. Rehse, K.-J. Schleifer, T. Ciborski, H. Bohn, Arch. Pharm. (Weinheim) 1993, 326, 791-797.
15. K. Rehse, M. Herpel, D. Piechocki, Arch. Pharm. Pharm. Med. Chem. 1996, 329, 83-86.
16. K. Rehse, D. Piechocki, M. Schober, H. Scheffler, N. Reitner, E. Unsöld, Arch. Pharm. Pharm. Med. Chem. 1996, 329, 511-513.
17. L. Sachs, Angewandte Statistik, Springer Verlag, 1984, p. 230,.
18. [17a] L. Sachs, Angewandte Statistik, Springer Verlag, 1992, p. 163.
19. K. Rehse, A. Kesselhut, C. Schein, M. Kämpfe, B. Rose, E. Unsöld, Arch. Pharm. (Weinheim) 1991, 324, 301-305.
20. K. Rehse, T. Ciborski, Arch. Pharm. (Weinheim) 1995, 328, 71-75.
21. M. Busch, C. Heinrichs, Ber. Dtsch. Chem. Ges. 1901, 33, 455-463.
22. M. Keim, M. Feelisch, R. Grube, W. Motz, B.E. Steuer, Metabolism of endothelium-derived nitric oxide in human blood. In The Biology of Nitric Oxide, I: Clinical Aspects (S. Moncada, M.A. Marletta, J.B. Jr. Hibbs, E.A. Higgs, eds), Portland Press, Colchester 1992, 319-22.